Darolutamide 300 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 300 mg

Reference Brands: Nubeqa (USA/EU)

Category: Oncology Cancer Care

Darolutamide is a Oncology Cancer Care product available as Tablets in strengths 300 mg. It corresponds to the reference brand Nubeqa (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Darolutamide, marketed under the brand name Nubeqa, is a nonsteroidal antiandrogen used for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) in men. It is specifically indicated for patients whose disease progresses despite surgical or medical castration, helping to slow tumor growth and delay metastasis. Darolutamide works by selectively binding to androgen receptors, inhibiting androgen-mediated signaling that contributes to prostate cancer cell proliferation. This mechanism helps reduce the stimulation of cancer cells by male hormones, providing effective disease control. The medication is administered orally, typically as a 300 mg tablet taken twice daily with food, ensuring optimal absorption and consistent plasma levels. Darolutamide has been shown to have a favorable safety profile, with fewer central nervous system-related side effects compared to other antiandrogens, while common adverse effects may include fatigue, joint pain, and elevated liver enzymes. Its oral route, targeted action, and manageable tolerability make darolutamide a valuable option for men with nmCRPC seeking to maintain quality of life while effectively managing disease progression. Regular monitoring by healthcare professionals ensures safe and effective therapy.